Methods of treating pr-positive, luminal a breast cancer with pi3k inhibitor, pictilisib

MA40271AUndetermined Publication Date: 2017-03-29F HOFFMANN LA ROCHE & CO AG +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40271
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-05-21
Filing Date: 2015-05-20
Publication Date: 2017-03-29

Application Information

Patent Timeline

21 May 2014

Priority

20 May 2015

Application

MA40271

29 Mar 2017

Publication

MA40271A

IPC: A61K31/381; A61K31/495; A61P35/00

CPC: A61K31/5377; A61K45/06; C12Q1/6886; G01N33/5011; G01N2333/916; G01N2333/91215; C12Q2600/156; C12Q2600/158

Inventors: DERYNCK Mika K.; FRIEDMAN Lori

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

Methods and compositions are provided for treating breast cancer in patients with a pi3k inhibitor, gdc-0941 in combination with an endocrine therapy agent.

Need to check novelty before this filing date? Find Prior Art